J. Mokrosz

发表

Structure-activity relationship studies of CNS agents. Part 29. N-Methylpiperazino-substituted derivatives of quinazoline, phthalazine and quinoline as novel α1, 5-HT1A and 5-HT2A receptor ligands

L. Strekowski,, A. Bojarski, L. Janda, 1996 .

Molecular basis for bleomycin amplification: conformational and stereoelectronic effects in unfused amplifiers.

L. Strekowski,, W. Wilson, F. Tanious, 1988, Journal of medicinal chemistry.

A non-classical intercalation model for a bleomycin amplifier.

L. Strekowski,, W. Wilson, G. J. Palenik, 1988, Anti-cancer drug design.

Recent Progress in Barbituric Acid Chemistry

J. Bojarşki, J. Mokrosz, H. Bartoń, 1985 .

Linear free energy relationship in thin layer chromatography of 5-arylidenebarbiturates

J. Mokrosz, L. Ekiert, 1984 .

Recent Progress in Barbituric Acid Chemistry

J. Bojarşki, J. Mokrosz, H. Bartoń, 1985 .

Spirans—XIII : UV—absorption of some spirans

J. Mokrosz, J. Nowicka, S. Smoliński, 1977 .

Structure‐Activity Relationship Studies of CNS Agents, Part 22: A Search for New Trazodone‐Like Antidepressants: Synthesis and Preliminary Receptor Binding Studies

M. Mokrosz, J. Mokrosz, B. Duszyńska, 1995, Archiv der Pharmazie.

Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents.

L. Strekowski,, R. Schinazi, S. Patterson, 1991, Journal of medicinal chemistry.

The Effect of Aryl Substituents in Some Spiro[2‐oxo‐4, 6‐bis (aryl)hexahydropyrimidine‐5,5′‐barbituric acids]

J. Mokrosz, E. Szneler, M. Paluchowska, 1989 .

Regioselective additions of grignard and lithium reagents to 2-[(benzylidene)aminoi]benzonitrile and 2-[(diphenylmethylene)amino]benzonitrile

L. Strekowski,, D. Harden, M. Mokrosz, 1988 .

Photolytic Synthesis of N-(2-Ethylbutyryl)-N′-substituted Imidodicarbonic Diamides

J. Mokrosz, E. Szneler, H. Bartoń, 1987 .

Hydrolysis of barbituric acid derivatives. Part 6. Hydrolysis of spirocyclopropane- and spiro-2′-methylcyclopropane-1′,5-barbituric acids

J. Mokrosz, M. Paluchowska, 1987 .

The Dissociation Constants of Some 1,5,5‐Trisubstituted Barbituric Acids

J. Bojarşki, J. Mokrosz, W. Wełna, 1986 .

Ring Deformation in Spirocyclopropane‐ and Spirocyclobutane‐1′,5‐barbituric Acids

J. Mokrosz, 1986 .

Mass spectrometry of spirobarbiturates

J. Mokrosz, 1985 .

Structure‐Reactivity Relationships in Barbiturates

J. Mokrosz, 1984 .

Structure-activity relationship studies of central nervous system agents. 13. 4-[3-(Benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)piperazine, a new putative 5-HT1A receptor antagonist, and its analogs.

M. Filip, M. Mokrosz, J. Mokrosz, 1994, Journal of medicinal chemistry.

Structure and spectral properties of β-carbolines. Part 4. Synthesis of the new ring system: 9,10,15,15b-tetrahydroindolo[1′,2′ : 4,3]pyrazino[2,1-a]-carbolin-7(6H)-one

Z. Bielecka, J. Mokrosz, S. Misztal, 1991 .

Synthesis and stereochemistry of new trihydrodiazabicyclo-[3.m.n]alkano[4′,5′:1,2]pyrido[3,4-b]indole ring system

M. Mokrosz, J. Mokrosz, M. Paluchowska, 1993 .

Amplification of bleomycin-mediated degradation of DNA by polyamines.

L. Strekowski,, W. Wilson, A. Strekowska, 1988, Anti-cancer drug design.

Quantitative structure-activity relationship analysis of cation-substituted polyaromatic compounds as potentiators (amplifiers) of bleomycin-mediated degradation of DNA.

L. Strekowski,, W. Wilson, S. Crow, 1991, Journal of medicinal chemistry.

Photochemical ring opening of barbital

J. Bojarşki, J. Mokrosz, H. Bartoń, 1982 .

5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.

T. Kowalska, P. Kowalski, E. Tatarczyńska, 1997, Pharmazie.

Structure and spectral properties of β-carbolines. 8. Mechanism of the Pictet-Spengler cyclization: An MNDO approach☆

A. Bojarski, P. Kowalski, J. Mokrosz, 1995 .

3‐(ω‐Aminoalkyl)‐5,5‐dialkyl(or spirocycloalkyl‐1′,5‐)hydantoins as New 5‐HT1A and 5‐HT2A Receptor Ligands.

M. Pawłowski, M. Mokrosz, J. Mokrosz, 1996 .

Structure‐Activity Relationship Studies of CNS Agents, Part 26 4‐[2‐(Cycloalkanecarboxamido)ethyl]‐1‐(2‐methoxyphenyl)‐piperazines: High‐Affinity 5‐HT1A Agonists

A. Kłodzińska, J. Mokrosz, S. Charakchieva‐Minol, 1995 .

Structure‐Activity Relationship Studies of CNS Agents, XXI: Two Derivatives of 1‐(o‐Methoxyphenyl)piperazine with an Opposite Function at 5‐HT1A Receptors

A. Bojarski, A. Kłodzińska, J. Mokrosz, 1995, Archiv der Pharmazie.

Structure-activity relationship studies of CNS agents, XV: N-[omega-(4-aryl-1-piperazinyl)alkyl]-2-oxo-1,2,3,4-tetrahydroquinoline s and -4-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indoles: new, highly potent 5-HT1A ligands.

J. Mokrosz, B. Duszyńska, M. Paluchowska, 1994, Archiv der Pharmazie.

Oxidation of 2,3‐Bis(hydroxymethyl)indole

Z. Bielecka, J. Mokrosz, S. Misztal, 1989 .

Structure-Activity Relationship Studies of CNS Agents. Part 18. 1-((2- Methoxyphenyl)-4-(4-succinimido)butyl)piperazine (MM-77): A New, Potent, Postsynaptic Antagonist of 5-HT1A Receptors.

M. Filip, E. Tatarczyńska, A. Kłodzińska, 1995 .

Structure‐Activity Relationship Studies of CNS Agents, XIX: Quantitative Analysis of the Alkyl Chain Effects on the 5‐HT1A and 5‐HT2 Receptor Affinities of 4‐Alkyl‐1‐arylpiperazines and Their Analogs

A. Bojarski, M. Mokrosz, J. Mokrosz, 1995, Archiv der Pharmazie.

4,6-Di(heteroaryl)-2-(N-methylpiperazino)pyrimidines as New, Potent 5-HT2A Receptor Ligands: A Verification of the Topographic Model

L. Strekowski,, A. Bojarski, S. Dove, 1996 .

Structure‐Activity Relationship Studies of CNS Agents, XV: N‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydroquinolines and ‐4‐oxo‐1,2,3,4‐tetrahydropyrazino[1,2‐a]indoles: New, Highly Potent 5‐HT1A Ligands ωN‐[ω‐(4‐Aryl‐1‐piperazinyl)alkyl]‐2‐oxo‐1,2,3,4‐tetrahydrochinoline und ‐4‐oxo‐1,2,3

J. Mokrosz, B. Duszyńska, M. Paluchowska, 2022 .

8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.

A. Bojarski, E. Tatarczyńska, M. Mokrosz, 1996, Journal of medicinal chemistry.

Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines.

A. Bojarski, M. Maćkowiak, M. Mokrosz, 1993, Die Pharmazie.

Structure-Activity Relationship Studies of CNS Agents. Part 6. Effect of the Terminal Amide Fragment on 5-HT1A and 5-HT2 Receptor Affinity for N-(3-(4-Aryl-1-piperazinyl)propyl) Derivatives of 3,4- Dihydroquinolin-2(1H)-one and Its Isomeric Isoquinolinones.

A. Bojarski, Z. Bielecka, M. Maćkowiak, 1992 .

3‐(ω‐Aminoalkyl)‐5,5‐dialkyl(or spirocycloalkyl‐1′,5‐)hydantoins as New 5‐HT1A and 5‐HT2A Receptor Ligands

M. Pawłowski, M. Mokrosz, J. Mokrosz, 1996 .

On the Conformation of 1‐Aryl‐1,4‐dihydro‐3(2H)‐isoquinolinones

J. Mokrosz, E. Szneler, M. Cegła, 1992 .

Structure and Spectral Properties of β‐Carbolines, I: 13C‐NMR and Mass Spectra of Decahydro‐5H‐pyrido[1′,2′;5,1]‐imidazo[3,4‐a]‐β‐carbolines

M. Dukat, J. Mokrosz, S. Misztal, 1990 .

Structure‐Activity Relationship Studies of CNS Agents, Part 23[1]): N‐(3‐Phenylpropyl)‐ and N‐[3(E)‐Cinnamyl]‐1,2,3,4‐tetrahydroisoquinoline Mimic 1‐Phenylpiperazine at 5‐HT1A Receptors

A. Bojarski, M. Mokrosz, J. Mokrosz, 1995 .

Structure‐Activity Relationship Studies of CNS Agents, Part 25: 4,6‐Di(heteroaryl)‐2‐(N‐methylpiperazino)pyrimidines as New, Potent 5‐HT2A Receptor Ligands: A Verification of the Topographic Model

L. Strekowski,, A. Bojarski, S. Dove, 1996, Archiv der Pharmazie.

Stereoelectronic factors in the interaction with DNA of small aromatic molecules substituted with a short cationic chain: importance of the polarity of the aromatic system of the molecule.

L. Strekowski,, W. Wilson, M. Mokrosz, 1992, Biochemistry.

Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.

L. Strekowski,, A. Bojarski, D. Harden, 1994, Die Pharmazie.